GE HealthCare Technologies Inc. Common Stock vs Uber Technologies Inc — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $69.4 (market cap $30.93B), while Uber Technologies Inc trades at $69.06 (market cap $141.53B). The key difference: Uber Technologies Inc is far larger — about 4.6× GE HealthCare Technologies Inc. Common Stock's market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while Uber Technologies Inc pays none. Which is the better fit depends on your goals.
| GEHC | UBER | |
|---|---|---|
Market Cap | $30.93B | $141.53B |
Volume | 5,033,451 | 15,688,591 |
Sector | Health | Technology |
52-Week High | $88.16 | $99.72 |
52-Week Low | $59.48 | $65.94 |
Enterprise Value | $39.39B | $150.87B |
Dividend Yield | 0.23% | — |
Typical Hold Time | — | 88 Days |
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Uber Technologies (UBER) trades at $71.32, down 0.25% on the day, with strong fundamental momentum as revenue grew to $52.02 billion in 2025 and net income reached $10.05 billion. The stock shows a bullish technical signal despite mixed moving averages, with key support at $69-70. Recent expansion of the Costco delivery partnership to 47 states and CEO share purchases of $10 million signal confidence in growth prospects.
Uber presents a compelling investment case with 82.5% analyst buy ratings and a $104.72 consensus target, representing 47% upside. Risks include projected negative cash flow in 2026 and competitive pressures in autonomous vehicles. The company's transition to sustained profitability and strategic partnerships support long-term growth potential despite near-term execution challenges.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →Uber Technologies is a technology provider that matches riders with drivers, hungry people with restaurants and food delivery service providers, and shippers with carriers. The firm's on-demand technology platform could eventually be used for additional products and services, such as autonomous vehicles, delivery via drones, and Uber Elevate, which, as the firm refers to it, provides aerial ride-sharing. Uber Technologies is headquartered in San Francisco and operates in over 63 countries with over 110 million users that order rides or foods at least once a month. Approximately 76% of its gross revenue comes from ride-sharing and 22% from food delivery.
Read more on UBER →